"You decide and we provide."
Cart 0

Novartis touts new T-cell therapy data in race for FDA approval




reutersCOMPANYNEWS companyNews

ZURICH, June 7 (Reuters) - Novartis on Wednesday touted new data from its T-cell therapy CTL019, saying it is on a par with results of experimental molecules from Kite Pharma and Juno Therapeutics that also target aggressive blood cancers.




Older Post Newer Post


Leave a comment

Please note, comments must be approved before they are published